Index of reports
> Cases with Angioedema (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ancef (Cefazolin) where reactions include angioedema. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ancef side effects in 78 year old female
Reported by a physician from Canada on 2012-04-20
Patient: 78 year old female
Reactions: LIP Swelling, Pruritus, Rash Generalised, Angioedema, Hypotension, Immunodeficiency, Febrile Neutropenia, Swollen Tongue, Pyrexia, Neuropathy Peripheral, Feeling Hot, Dermatitis Bullous, Neutropenia, Dermatitis Exfoliative, Rash Maculo-Papular
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tobi
Dosage: unk
Indication: Febrile Neutropenia
Start date: 2010-11-04
End date: 2010-11-05
Lenalidomide
Dosage: 25 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2010-10-29
Ancef
Dosage: unk
Start date: 2010-11-04
End date: 2010-11-05
Other drugs received by patient: Velcade
Possible Ancef side effects in 78 year old female
Reported by a physician from Canada on 2012-04-18
Patient: 78 year old female
Reactions: Neuropathy Peripheral, Angioedema, Febrile Neutropenia, Rash Maculo-Papular
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tobramycin
Indication: Febrile Neutropenia
Start date: 2010-11-04
End date: 2010-11-05
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2010-10-29
End date: 2010-11-09
Ancef
Indication: Febrile Neutropenia
Start date: 2010-11-04
End date: 2010-11-05
Other drugs received by patient: Velcade
Possible Ancef side effects in female
Reported by a physician from Canada on 2011-10-19
Patient: female
Reactions: Angioedema, Neuropathy Peripheral, Febrile Neutropenia, Rash Maculo-Papular
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tobramycin
Indication: Febrile Neutropenia
Start date: 2010-11-04
End date: 2010-11-05
Ancef
Indication: Febrile Neutropenia
Start date: 2010-11-04
End date: 2010-11-05
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2010-10-29
End date: 2010-11-09
Other drugs received by patient: Velcade
|